208 related articles for article (PubMed ID: 17565339)
21. Bisphosphonates for breast cancer: questions answered, questions remaining.
Layman R; Olson K; Van Poznak C
Hematol Oncol Clin North Am; 2007 Apr; 21(2):341-67. PubMed ID: 17512453
[TBL] [Abstract][Full Text] [Related]
22. Intravenous bisphosphonates for breast cancer: impact on patient outcomes and scientific concepts.
Gnant M
Breast Dis; 2011; 33(2):71-81. PubMed ID: 22142663
[TBL] [Abstract][Full Text] [Related]
23. Denosumab and the current status of bone-modifying drugs in breast cancer.
Lee BL; Higgins MJ; Goss PE
Acta Oncol; 2012 Feb; 51(2):157-67. PubMed ID: 22150116
[TBL] [Abstract][Full Text] [Related]
24. Too much, too little, too late to start again? Assessing the efficacy of bisphosphonates in patients with bone metastases from breast cancer.
Clemons M; Dranitsaris G; Cole D; Gainford MC
Oncologist; 2006 Mar; 11(3):227-33. PubMed ID: 16549806
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant clodronate in breast cancer.
Paterson AH
Acta Oncol; 2005; 44(1):80-2; author reply 83-4. PubMed ID: 15848910
[No Abstract] [Full Text] [Related]
26. Routine adjuvant use of bisphosphonates in breast cancer arguments in favour and against.
Diel I; Aebi S
Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S11-5. PubMed ID: 20427027
[No Abstract] [Full Text] [Related]
27. Advances in management of bone disease in breast cancer.
Walkington L; Coleman RE
Bone; 2011 Jan; 48(1):80-7. PubMed ID: 20621652
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.
Hadji P; Coleman RE; Wilson C; Powles TJ; Clézardin P; Aapro M; Costa L; Body JJ; Markopoulos C; Santini D; Diel I; Di Leo A; Cameron D; Dodwell D; Smith I; Gnant M; Gray R; Harbeck N; Thurlimann B; Untch M; Cortes J; Martin M; Albert US; Conte PF; Ejlertsen B; Bergh J; Kaufmann M; Holen I
Ann Oncol; 2016 Mar; 27(3):379-90. PubMed ID: 26681681
[TBL] [Abstract][Full Text] [Related]
29. Use of bisphosphonates in cancer patients.
Body JJ; Coleman RE; Piccart M
Cancer Treat Rev; 1996 Jul; 22(4):265-87. PubMed ID: 9025784
[No Abstract] [Full Text] [Related]
30. Bisphosphonates in breast cancer: a triple winner?
Mathew A; Brufsky A
Oncology (Williston Park); 2015 Jan; 29(1):37-9. PubMed ID: 25595284
[No Abstract] [Full Text] [Related]
31. Bisphosphonates and breast cancer incidence and recurrence.
Chlebowski RT; Col N
Breast Dis; 2011; 33(2):93-101. PubMed ID: 22142660
[TBL] [Abstract][Full Text] [Related]
32. Alendronate-Modified Polymeric Micelles for the Treatment of Breast Cancer Bone Metastasis.
Liu T; Romanova S; Wang S; Hyun MA; Zhang C; Cohen SM; Singh RK; Bronich TK
Mol Pharm; 2019 Jul; 16(7):2872-2883. PubMed ID: 31150251
[TBL] [Abstract][Full Text] [Related]
33. [Bisphosphonates in the treatment of breast carcinoma].
Stajszczyk M; Mykała-Cieśla J
Pol Arch Med Wewn; 2001 Aug; 106(2):729-38. PubMed ID: 11926150
[No Abstract] [Full Text] [Related]
34. Pharmacotherapy of bone metastases in breast cancer patients.
Petrut B; Simmons C; Broom R; Trinkaus M; Clemons M
Expert Opin Pharmacother; 2008 Apr; 9(6):937-45. PubMed ID: 18377337
[TBL] [Abstract][Full Text] [Related]
35. Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].
Powles T; Paterson A; McCloskey E; Schein P; Scheffler B; Tidy A; Ashley S; Smith I; Ottestad L; Kanis J
Breast Cancer Res; 2006; 8(2):R13. PubMed ID: 16542503
[TBL] [Abstract][Full Text] [Related]
36. Emerging role for bisphosphonates in cancer management.
Chlebowski RT
Breast Dis; 2011; 33(2):55-7. PubMed ID: 22142659
[No Abstract] [Full Text] [Related]
37. Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials.
Machado M; Cruz LS; Tannus G; Fonseca M
Clin Ther; 2009 May; 31(5):962-79. PubMed ID: 19539097
[TBL] [Abstract][Full Text] [Related]
38. Should oral bisphosphonates be standard of care in women with early breast cancer?
Clemons M; Verma S
Breast Cancer Res Treat; 2005 Apr; 90(3):315-8. PubMed ID: 15830146
[TBL] [Abstract][Full Text] [Related]
39. Bisphosphonates as adjuvant therapy.
Shapiro CL
Clin Adv Hematol Oncol; 2009 May; 7(5):319-20. PubMed ID: 19521319
[No Abstract] [Full Text] [Related]
40. Bisphosphonates: game changers?
Craig Henderson I
Oncology (Williston Park); 2015 Jan; 29(1):16, 42. PubMed ID: 25595282
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
